Conditions: Wet Macular Degeneration
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 14
Healthy volunteers: no

Brief summary:
The present trial will use an open label design to investigate the effect of BI 144807 on central 1-mm retinal thickness and presence of neovascular leakage in newly diagnosed wAMD patients. A further objective is to collect data on adverse events, vital signs, ECG and clinical laboratory parameters of BI 144807 in the same patient group.

Detailed description:

Arms:
arm 1: twice daily

Interventions: intervention 1: BI 144807
Intervention descriptions: intervention 1: twice daily

Protocol document: